Evidence map›Paper›PMID 39626017›Full record

ArticleACS infectious diseases2024

Structure Elucidation of the Daptomycin Products Generated upon Heterologous Expression of the Daptomycin Resistance Gene Cluster

Lukas Kirchner, Tessa Marciniak, Christine Erk, Wilma Ziebuhr, Oliver Scherf-Clavel, Ulrike Holzgrabe

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in ACS infectious diseases, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Lukas KirchnerInstitute for Pharmacy and Food Chemistry, University of Würzburg, 97074 Würzburg, Germany.ORCID 0000-0001-5880-4229
Tessa MarciniakInstitute for Molecular Infection Biology, University of Würzburg, 97080 Würzburg, Germany.
Christine ErkInstitute for Pharmacy and Food Chemistry, University of Würzburg, 97074 Würzburg, Germany.
Wilma ZiebuhrInstitute for Molecular Infection Biology, University of Würzburg, 97080 Würzburg, Germany.
Oliver Scherf-ClavelDepartment of Pharmacy, Ludwig-Maximilians-Universität München, 81377 München, Germany.
Ulrike HolzgrabeInstitute for Pharmacy and Food Chemistry, University of Würzburg, 97074 Würzburg, Germany.ORCID 0000-0002-0364-7278

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Recently, a high-level daptomycin (DAP)-resistant

Indexed as

Anti-Bacterial AgentsDaptomycinDrug Resistance, BacterialMultigene FamilyStaphylococcus aureusBacterial ProteinsGene Expression Regulation, BacterialMass SpectrometryMicrobial Sensitivity TestsOperonAnti-Bacterial AgentsBacterial ProteinsDaptomycinantimicrobial resistancedaptomycingeneral unknown comparative screening (GUCS)high-resolution mass spectrometry (HRMS)structural elucidation

Identifiers

PMID39626017
PMCPMC11650644

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.